The New England journal of medicine, 2022-11, Vol.387 (21), p.1923-1934
- Das Pradhan, Aruna
- Glynn, Robert J.
- Fruchart, Jean-Charles
- MacFadyen, Jean G.
- Zaharris, Elaine S.
- Everett, Brendan M.
- Campbell, Stuart E.
- Oshima, Ryu
- Amarenco, Pierre
- Blom, Dirk J.
- Brinton, Eliot A.
- Eckel, Robert H.
- Elam, Marshall B.
- Felicio, João S.
- Ginsberg, Henry N.
- Goudev, Assen
- Ishibashi, Shun
- Joseph, Jacob
- Kodama, Tatsuhiko
- Koenig, Wolfgang
- Leiter, Lawrence A.
- Lorenzatti, Alberto J.
- Mankovsky, Boris
- Marx, Nikolaus
- Nordestgaard, Børge G.
- Páll, Dénes
- Ray, Kausik K.
- Santos, Raul D.
- Soran, Handrean
- Susekov, Andrey
- Tendera, Michal
- Yokote, Koutaro
- Paynter, Nina P.
- Buring, Julie E.
- Libby, Peter
- Ridker, Paul M
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Das Pradhan, Aruna
- Glynn, Robert J.
- Fruchart, Jean-Charles
- MacFadyen, Jean G.
- Zaharris, Elaine S.
- Everett, Brendan M.
- Campbell, Stuart E.
- Oshima, Ryu
- Amarenco, Pierre
- Blom, Dirk J.
- Brinton, Eliot A.
- Eckel, Robert H.
- Elam, Marshall B.
- Felicio, João S.
- Ginsberg, Henry N.
- Goudev, Assen
- Ishibashi, Shun
- Joseph, Jacob
- Kodama, Tatsuhiko
- Koenig, Wolfgang
- Leiter, Lawrence A.
- Lorenzatti, Alberto J.
- Mankovsky, Boris
- Marx, Nikolaus
- Nordestgaard, Børge G.
- Páll, Dénes
- Ray, Kausik K.
- Santos, Raul D.
- Soran, Handrean
- Susekov, Andrey
- Tendera, Michal
- Yokote, Koutaro
- Paynter, Nina P.
- Buring, Julie E.
- Libby, Peter
- Ridker, Paul M
- Titel
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- Ist Teil von
- The New England journal of medicine, 2022-11, Vol.387 (21), p.1923-1934
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a randomized trial, patients with type 2 diabetes, hypertriglyceridemia, and low HDL cholesterol who received pemafibrate did not have fewer cardiovascular events, although some lipid levels decreased.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2210645Titel-ID: cdi_proquest_miscellaneous_2733200330
- Format
- –
- Schlagworte
- Apolipoprotein B, Apolipoprotein C-III, Apolipoprotein C-III - blood, Apolipoproteins, Biomarkers, Cardiology, Cardiology General, Cardiovascular disease, Cardiovascular diseases, Cardiovascular Diseases - epidemiology, Cardiovascular Diseases - etiology, Cerebral infarction, Cholesterol, Cholesterol - blood, Cholesterol, HDL - blood, Cholesterol, LDL - blood, Clinical Medicine, Clinical Medicine General, Coronary Disease, Design, Diabetes, Diabetes mellitus (non-insulin dependent), Diabetes Mellitus, Type 2 - complications, Disease prevention, Double-Blind Method, Fatty liver, Heart attacks, Heart Disease Risk Factors, Heart failure, High density lipoprotein, Hospital-Based Clinical Medicine, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Hyperlipidemias - blood, Hyperlipidemias - drug therapy, Hypertriglyceridemia, Hypertriglyceridemia - blood, Hypertriglyceridemia - complications, Hypertriglyceridemia - drug therapy, Hypolipidemic Agents - therapeutic use, Ischemia, Lipids, Lipolysis, Lipoproteins, Lipoproteins (very low density), Liver diseases, Low density lipoprotein, Myocardial Infarction, Outpatient-Based Clinical Medicine, Placebos, PPAR alpha - agonists, Prevention, Research centers, Risk Factors, Statins, Statistical analysis, Thromboembolism, Triglycerides, Triglycerides - blood